

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 4.91727739 |
| 2 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 4.72697785 |
| 3 | locomotory exploration behavior (GO:0035641) | 4.59139959 |
| 4 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 4.44874544 |
| 5 | regulation of fibrinolysis (GO:0051917) | 4.42934249 |
| 6 | synaptic vesicle maturation (GO:0016188) | 4.26452680 |
| 7 | vocalization behavior (GO:0071625) | 4.25975430 |
| 8 | neuron cell-cell adhesion (GO:0007158) | 4.25108141 |
| 9 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.07897549 |
| 10 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.07687125 |
| 11 | peptidyl-glutamic acid carboxylation (GO:0017187) | 4.01472780 |
| 12 | protein carboxylation (GO:0018214) | 4.01472780 |
| 13 | synaptic vesicle exocytosis (GO:0016079) | 3.98444519 |
| 14 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.96919672 |
| 15 | central nervous system myelination (GO:0022010) | 3.91723265 |
| 16 | axon ensheathment in central nervous system (GO:0032291) | 3.91723265 |
| 17 | very-low-density lipoprotein particle assembly (GO:0034379) | 3.90481890 |
| 18 | protein localization to synapse (GO:0035418) | 3.88177354 |
| 19 | regulation of protein activation cascade (GO:2000257) | 3.84110492 |
| 20 | glutamate secretion (GO:0014047) | 3.80924674 |
| 21 | dendritic spine morphogenesis (GO:0060997) | 3.80430679 |
| 22 | neuronal action potential propagation (GO:0019227) | 3.78405682 |
| 23 | regulation of complement activation (GO:0030449) | 3.73326687 |
| 24 | regulation of glutamate receptor signaling pathway (GO:1900449) | 3.71724433 |
| 25 | hemidesmosome assembly (GO:0031581) | 3.71699087 |
| 26 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.69720610 |
| 27 | cell adhesion mediated by integrin (GO:0033627) | 3.66459062 |
| 28 | glutamate receptor signaling pathway (GO:0007215) | 3.65715007 |
| 29 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 3.63357205 |
| 30 | exploration behavior (GO:0035640) | 3.61901987 |
| 31 | regulation of apoptotic cell clearance (GO:2000425) | 3.61890473 |
| 32 | gamma-aminobutyric acid transport (GO:0015812) | 3.61604804 |
| 33 | presynaptic membrane assembly (GO:0097105) | 3.60400909 |
| 34 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.58102993 |
| 35 | neuron recognition (GO:0008038) | 3.53125642 |
| 36 | plasma lipoprotein particle assembly (GO:0034377) | 3.51998119 |
| 37 | transmission of nerve impulse (GO:0019226) | 3.47043721 |
| 38 | presynaptic membrane organization (GO:0097090) | 3.46012933 |
| 39 | synaptic transmission, glutamatergic (GO:0035249) | 3.44730268 |
| 40 | protein-lipid complex assembly (GO:0065005) | 3.43838379 |
| 41 | complement activation, alternative pathway (GO:0006957) | 3.43268562 |
| 42 | regulation of plasminogen activation (GO:0010755) | 3.38666119 |
| 43 | neuron-neuron synaptic transmission (GO:0007270) | 3.37474259 |
| 44 | regulation of cholesterol homeostasis (GO:2000188) | 3.34896506 |
| 45 | cytoskeletal anchoring at plasma membrane (GO:0007016) | 3.34593907 |
| 46 | COPI coating of Golgi vesicle (GO:0048205) | 3.32210937 |
| 47 | Golgi transport vesicle coating (GO:0048200) | 3.32210937 |
| 48 | neurotransmitter-gated ion channel clustering (GO:0072578) | 3.28549972 |
| 49 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.27614719 |
| 50 | neurotransmitter secretion (GO:0007269) | 3.27076325 |
| 51 | layer formation in cerebral cortex (GO:0021819) | 3.26355035 |
| 52 | L-amino acid import (GO:0043092) | 3.25731581 |
| 53 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.24813608 |
| 54 | axonal fasciculation (GO:0007413) | 3.24596949 |
| 55 | protein retention in ER lumen (GO:0006621) | 3.24042590 |
| 56 | skin morphogenesis (GO:0043589) | 3.21502278 |
| 57 | regulation of dendritic spine morphogenesis (GO:0061001) | 3.19509023 |
| 58 | cholesterol efflux (GO:0033344) | 3.17341610 |
| 59 | regulation of synaptic vesicle transport (GO:1902803) | 3.17298660 |
| 60 | regulation of cholesterol esterification (GO:0010872) | 3.16781627 |
| 61 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 3.14996610 |
| 62 | dendrite morphogenesis (GO:0048813) | 3.11278302 |
| 63 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.11039621 |
| 64 | long-term memory (GO:0007616) | 3.10213781 |
| 65 | basement membrane organization (GO:0071711) | 3.08978314 |
| 66 | regulation of postsynaptic membrane potential (GO:0060078) | 3.08090531 |
| 67 | positive regulation of extracellular matrix organization (GO:1903055) | 3.08072175 |
| 68 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 3.07448269 |
| 69 | regulation of synapse structural plasticity (GO:0051823) | 3.06197830 |
| 70 | neuronal ion channel clustering (GO:0045161) | 3.05407125 |
| 71 | fibrinolysis (GO:0042730) | 3.04708312 |
| 72 | negative regulation of neurotransmitter transport (GO:0051589) | 3.02777219 |
| 73 | negative regulation of fatty acid transport (GO:2000192) | 3.01989001 |
| 74 | negative regulation of cholesterol transport (GO:0032375) | 3.01650739 |
| 75 | negative regulation of sterol transport (GO:0032372) | 3.01650739 |
| 76 | positive regulation of membrane potential (GO:0045838) | 2.98555257 |
| 77 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.96953644 |
| 78 | auditory behavior (GO:0031223) | 2.96422566 |
| 79 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.94904153 |
| 80 | regulation of cholesterol biosynthetic process (GO:0045540) | 2.93688808 |
| 81 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.93144544 |
| 82 | behavioral response to cocaine (GO:0048148) | 2.91679661 |
| 83 | intestinal cholesterol absorption (GO:0030299) | 2.90369175 |
| 84 | protein-lipid complex remodeling (GO:0034368) | 2.89344153 |
| 85 | macromolecular complex remodeling (GO:0034367) | 2.89344153 |
| 86 | plasma lipoprotein particle remodeling (GO:0034369) | 2.89344153 |
| 87 | regulation of synaptic plasticity (GO:0048167) | 2.88909754 |
| 88 | protein localization to endosome (GO:0036010) | 2.88437144 |
| 89 | long-term synaptic potentiation (GO:0060291) | 2.88297234 |
| 90 | regulation of dendritic spine development (GO:0060998) | 2.86694343 |
| 91 | cellular potassium ion homeostasis (GO:0030007) | 2.86646570 |
| 92 | negative regulation of lipid transport (GO:0032369) | 2.85816415 |
| 93 | neurotransmitter transport (GO:0006836) | 2.85663125 |
| 94 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 2.85274922 |
| 95 | low-density lipoprotein particle remodeling (GO:0034374) | 2.84110468 |
| 96 | cell-substrate junction assembly (GO:0007044) | 2.83194985 |
| 97 | adult walking behavior (GO:0007628) | 2.81975340 |
| 98 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 2.81344473 |
| 99 | mating behavior (GO:0007617) | 2.80729371 |
| 100 | cerebellar granule cell differentiation (GO:0021707) | 2.80572760 |
| 101 | nerve growth factor signaling pathway (GO:0038180) | 2.78642289 |
| 102 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.78634738 |
| 103 | neuromuscular process controlling balance (GO:0050885) | 2.76878418 |
| 104 | phospholipid efflux (GO:0033700) | 2.76829124 |
| 105 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.76749678 |
| 106 | proline transport (GO:0015824) | 2.76689073 |
| 107 | desmosome organization (GO:0002934) | 2.74162858 |
| 108 | fatty acid elongation (GO:0030497) | 2.72566990 |
| 109 | endodermal cell differentiation (GO:0035987) | 2.72403478 |
| 110 | glycine transport (GO:0015816) | 2.71359492 |
| 111 | plasma lipoprotein particle clearance (GO:0034381) | 2.70971928 |
| 112 | postsynaptic membrane organization (GO:0001941) | 2.70873618 |
| 113 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 2.68877344 |
| 114 | long-chain fatty acid biosynthetic process (GO:0042759) | 2.68680761 |
| 115 | membrane hyperpolarization (GO:0060081) | 2.68225704 |
| 116 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.67571694 |
| 117 | dendritic spine organization (GO:0097061) | 2.67360922 |
| 118 | regulation of neurotransmitter levels (GO:0001505) | 2.67066471 |
| 119 | blood coagulation, intrinsic pathway (GO:0007597) | 2.66727460 |
| 120 | protein-lipid complex subunit organization (GO:0071825) | 2.66506753 |
| 121 | response to auditory stimulus (GO:0010996) | 2.66429858 |
| 122 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.66412542 |
| 123 | positive regulation of blood coagulation (GO:0030194) | 2.65842230 |
| 124 | positive regulation of hemostasis (GO:1900048) | 2.65842230 |
| 125 | plasma lipoprotein particle organization (GO:0071827) | 2.65729095 |
| 126 | positive regulation of dendritic spine development (GO:0060999) | 2.65579757 |
| 127 | cellular response to prostaglandin stimulus (GO:0071379) | 2.63623480 |
| 128 | regulation of neurotransmitter secretion (GO:0046928) | 2.63096653 |
| 129 | * myelination (GO:0042552) | 2.62846597 |
| 130 | response to histamine (GO:0034776) | 2.62643276 |
| 131 | regulation of vesicle fusion (GO:0031338) | 2.62518968 |
| 132 | membrane depolarization (GO:0051899) | 2.60245319 |
| 133 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.59948878 |
| 134 | learning (GO:0007612) | 2.59250741 |
| 135 | activation of protein kinase A activity (GO:0034199) | 2.58712033 |
| 136 | regulation of glutamate secretion (GO:0014048) | 2.58700349 |
| 137 | synaptic vesicle endocytosis (GO:0048488) | 2.58327510 |
| 138 | negative regulation of blood coagulation (GO:0030195) | 2.58000193 |
| 139 | negative regulation of hemostasis (GO:1900047) | 2.58000193 |
| 140 | synapse assembly (GO:0007416) | 2.57991786 |
| 141 | * ensheathment of neurons (GO:0007272) | 2.57986383 |
| 142 | * axon ensheathment (GO:0008366) | 2.57986383 |
| 143 | positive regulation of coagulation (GO:0050820) | 2.56815904 |
| 144 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.56210526 |
| 145 | low-density lipoprotein particle clearance (GO:0034383) | 2.55941272 |
| 146 | COPII vesicle coating (GO:0048208) | 2.55378553 |
| 147 | regulation of extracellular matrix organization (GO:1903053) | 2.55134416 |
| 148 | insulin-like growth factor receptor signaling pathway (GO:0048009) | 2.54574465 |
| 149 | high-density lipoprotein particle remodeling (GO:0034375) | 2.54516879 |
| 150 | synapse organization (GO:0050808) | 2.54445765 |
| 151 | prepulse inhibition (GO:0060134) | 2.53918210 |
| 152 | regulation of respiratory gaseous exchange by neurological system process (GO:0002087) | 2.53236140 |
| 153 | mechanosensory behavior (GO:0007638) | 2.53165402 |
| 154 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.52820048 |
| 155 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 2.51931166 |
| 156 | sodium ion export (GO:0071436) | 2.51377082 |
| 157 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.51249625 |
| 158 | neuron remodeling (GO:0016322) | 2.50763296 |
| 159 | behavioral fear response (GO:0001662) | 2.50753878 |
| 160 | behavioral defense response (GO:0002209) | 2.50753878 |
| 161 | regulation of extracellular matrix disassembly (GO:0010715) | 2.50468413 |
| 162 | apoptotic cell clearance (GO:0043277) | 2.49955304 |
| 163 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.49877002 |
| 164 | negative regulation of lipase activity (GO:0060192) | 2.49330848 |
| 165 | establishment of mitochondrion localization (GO:0051654) | 2.47831879 |
| 166 | urea metabolic process (GO:0019627) | 2.46956407 |
| 167 | negative regulation of wound healing (GO:0061045) | 2.45368435 |
| 168 | alpha-linolenic acid metabolic process (GO:0036109) | 2.44213594 |
| 169 | reverse cholesterol transport (GO:0043691) | 2.41803834 |
| 170 | negative regulation of coagulation (GO:0050819) | 2.39181533 |
| 171 | lipoprotein metabolic process (GO:0042157) | 2.38261249 |
| 172 | positive regulation of steroid metabolic process (GO:0045940) | 2.37790154 |
| 173 | negative regulation of protein activation cascade (GO:2000258) | 2.37431455 |
| 174 | glutamate metabolic process (GO:0006536) | 2.36529199 |
| 175 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 2.36298662 |
| 176 | urea cycle (GO:0000050) | 2.34929435 |
| 177 | regulation of early endosome to late endosome transport (GO:2000641) | 2.34805040 |
| 178 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 2.34333803 |
| 179 | vesicle coating (GO:0006901) | 2.33652016 |
| 180 | regulation of bile acid biosynthetic process (GO:0070857) | 2.32699919 |
| 181 | intestinal absorption (GO:0050892) | 2.32446857 |
| 182 | L-phenylalanine metabolic process (GO:0006558) | 2.31531995 |
| 183 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.31531995 |
| 184 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.31250237 |
| 185 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.31250237 |
| 186 | chondrocyte proliferation (GO:0035988) | 2.30972471 |
| 187 | adherens junction assembly (GO:0034333) | 2.29357761 |
| 188 | semaphorin-plexin signaling pathway (GO:0071526) | 2.25539441 |
| 189 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.25164596 |
| 190 | epithelial cell-cell adhesion (GO:0090136) | 2.24708406 |
| 191 | focal adhesion assembly (GO:0048041) | 2.24335346 |
| 192 | cell-substrate adherens junction assembly (GO:0007045) | 2.24335346 |
| 193 | regulation of cholesterol metabolic process (GO:0090181) | 2.23473442 |
| 194 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.23427809 |
| 195 | platelet degranulation (GO:0002576) | 2.22862500 |
| 196 | cell-cell junction maintenance (GO:0045217) | 2.22853115 |
| 197 | barbed-end actin filament capping (GO:0051016) | 2.21117709 |
| 198 | acute-phase response (GO:0006953) | 2.20692102 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 4.72351258 |
| 2 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.66435618 |
| 3 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 3.90282003 |
| 4 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.50340314 |
| 5 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.93155833 |
| 6 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.86370771 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.84959736 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.83101582 |
| 9 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.75726888 |
| 10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.72805128 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.56147209 |
| 12 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.52647010 |
| 13 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.47070215 |
| 14 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.47070215 |
| 15 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.41487288 |
| 16 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 2.38738650 |
| 17 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.36202910 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.35398674 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.33153192 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.27998431 |
| 21 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.27606951 |
| 22 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.26042420 |
| 23 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.25343386 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.23923375 |
| 25 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.14625901 |
| 26 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 2.13644037 |
| 27 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 2.09589173 |
| 28 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 2.07856115 |
| 29 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 2.04328704 |
| 30 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.03271545 |
| 31 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.01183266 |
| 32 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.00997317 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.00142544 |
| 34 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.98857330 |
| 35 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.97583495 |
| 36 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.95895100 |
| 37 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.95548460 |
| 38 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.94539408 |
| 39 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.88410744 |
| 40 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.85575361 |
| 41 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.83447853 |
| 42 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.76203328 |
| 43 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.73856835 |
| 44 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.72512723 |
| 45 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.70425173 |
| 46 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.65721818 |
| 47 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.64955119 |
| 48 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.63214155 |
| 49 | KDM2B_26808549_Chip-Seq_K562_Human | 1.61657633 |
| 50 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.60574957 |
| 51 | TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 1.59206928 |
| 52 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.58636259 |
| 53 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.57875639 |
| 54 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.56335576 |
| 55 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.55505744 |
| 56 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.53592878 |
| 57 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.52375308 |
| 58 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.50358058 |
| 59 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.48992545 |
| 60 | P300_19829295_ChIP-Seq_ESCs_Human | 1.48884981 |
| 61 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 1.47909631 |
| 62 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.46000626 |
| 63 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.45962983 |
| 64 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.44981548 |
| 65 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.43981602 |
| 66 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.43172298 |
| 67 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 1.43108769 |
| 68 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.41102913 |
| 69 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.40337093 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.39977568 |
| 71 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.39781029 |
| 72 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.39732556 |
| 73 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.39177649 |
| 74 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.36492981 |
| 75 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.36260227 |
| 76 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.35809427 |
| 77 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.35428368 |
| 78 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.34754026 |
| 79 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.34635780 |
| 80 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.33243926 |
| 81 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.32160218 |
| 82 | DMRT1_23473982_ChIP-Seq_TESTES_Mouse | 1.31824247 |
| 83 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.31013996 |
| 84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30870687 |
| 85 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.30179329 |
| 86 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.29964456 |
| 87 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.29828396 |
| 88 | STAT3_23295773_ChIP-Seq_U87_Human | 1.29519036 |
| 89 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.29152567 |
| 90 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.28916389 |
| 91 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.28809715 |
| 92 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.28315454 |
| 93 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.27625270 |
| 94 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.27625270 |
| 95 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.27064804 |
| 96 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.26898420 |
| 97 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.26774957 |
| 98 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.26717669 |
| 99 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.25960292 |
| 100 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.24741714 |
| 101 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.24664129 |
| 102 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.23778064 |
| 103 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.23708046 |
| 104 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.23355496 |
| 105 | TP53_16413492_ChIP-PET_HCT116_Human | 1.23277550 |
| 106 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.22346080 |
| 107 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.22093720 |
| 108 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.21407044 |
| 109 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.20182461 |
| 110 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19500252 |
| 111 | AR_25329375_ChIP-Seq_VCAP_Human | 1.18404298 |
| 112 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.18372201 |
| 113 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.17277068 |
| 114 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.16834754 |
| 115 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.15986718 |
| 116 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.14925944 |
| 117 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.14738492 |
| 118 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.14009644 |
| 119 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.13928710 |
| 120 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.13866280 |
| 121 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.13789814 |
| 122 | TCF4_23295773_ChIP-Seq_U87_Human | 1.13448648 |
| 123 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.13064509 |
| 124 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.12323348 |
| 125 | ZFP281_27345836_Chip-Seq_ESCs_Mouse | 1.12241425 |
| 126 | SALL4_18804426_ChIP-ChIP_MESCs_Mouse | 1.11580931 |
| 127 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.10974432 |
| 128 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.10635002 |
| 129 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.10393110 |
| 130 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.09990690 |
| 131 | FUS_26573619_Chip-Seq_HEK293_Human | 1.09986295 |
| 132 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.08924974 |
| 133 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.08772343 |
| 134 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.07520560 |
| 135 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.07399313 |
| 136 | * AR_19668381_ChIP-Seq_PC3_Human | 1.07112189 |
| 137 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.05966922 |
| 138 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.05785493 |
| 139 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.05317760 |
| 140 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.03942609 |
| 141 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.03676270 |
| 142 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.03676270 |
| 143 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.03646160 |
| 144 | * RUNX2_22187159_ChIP-Seq_PCA_Human | 1.03020541 |
| 145 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.02081695 |
| 146 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.01977218 |
| 147 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 1.01890595 |
| 148 | * DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01694348 |
| 149 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.00584268 |
| 150 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.00526618 |
| 151 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.99765556 |
| 152 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.99765556 |
| 153 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.99622766 |
| 154 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.99579006 |
| 155 | TP53_22127205_ChIP-Seq_IMR90_Human | 0.99115196 |
| 156 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.98186176 |
| 157 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 0.97690198 |
| 158 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 0.97598015 |
| 159 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.96584970 |
| 160 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 0.96093092 |
| 161 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.95386092 |
| 162 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.94505606 |
| 163 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.94421933 |
| 164 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.94382109 |
| 165 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.94110733 |
| 166 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93604344 |
| 167 | VDR_22108803_ChIP-Seq_LS180_Human | 0.93568529 |
| 168 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 0.92965430 |
| 169 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.92546098 |
| 170 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.92131571 |
| 171 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.92131571 |
| 172 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.91427060 |
| 173 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.90797646 |
| 174 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.89502638 |
| 175 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.89383443 |
| 176 | RNF2_27304074_Chip-Seq_NSC_Mouse | 0.88769805 |
| 177 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.88486168 |
| 178 | CJUN_26792858_Chip-Seq_BT549_Human | 0.88096307 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.74790346 |
| 2 | MP0003880_abnormal_central_pattern | 4.70131080 |
| 3 | MP0008438_abnormal_cutaneous_collagen | 4.31466977 |
| 4 | MP0004270_analgesia | 3.77238990 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.72129074 |
| 6 | MP0003705_abnormal_hypodermis_morpholog | 3.71615077 |
| 7 | MP0009745_abnormal_behavioral_response | 3.20951279 |
| 8 | MP0004272_abnormal_basement_membrane | 3.17042057 |
| 9 | MP0002063_abnormal_learning/memory/cond | 3.00377518 |
| 10 | * MP0002064_seizures | 3.00365302 |
| 11 | MP0009046_muscle_twitch | 2.80904458 |
| 12 | MP0001486_abnormal_startle_reflex | 2.76664057 |
| 13 | MP0003566_abnormal_cell_adhesion | 2.72368803 |
| 14 | MP0005257_abnormal_intraocular_pressure | 2.71650027 |
| 15 | MP0005058_abnormal_lysosome_morphology | 2.70217070 |
| 16 | MP0002272_abnormal_nervous_system | 2.64867791 |
| 17 | MP0002822_catalepsy | 2.61444641 |
| 18 | MP0002572_abnormal_emotion/affect_behav | 2.59375862 |
| 19 | MP0010368_abnormal_lymphatic_system | 2.58026729 |
| 20 | MP0005365_abnormal_bile_salt | 2.56606898 |
| 21 | MP0003329_amyloid_beta_deposits | 2.50900237 |
| 22 | MP0005423_abnormal_somatic_nervous | 2.49761169 |
| 23 | MP0001968_abnormal_touch/_nociception | 2.47442856 |
| 24 | MP0009840_abnormal_foam_cell | 2.39127382 |
| 25 | MP0002734_abnormal_mechanical_nocicepti | 2.32226427 |
| 26 | * MP0000920_abnormal_myelination | 2.12763738 |
| 27 | MP0005275_abnormal_skin_tensile | 2.11119024 |
| 28 | MP0001440_abnormal_grooming_behavior | 2.07748734 |
| 29 | MP0009780_abnormal_chondrocyte_physiolo | 2.03275834 |
| 30 | MP0001501_abnormal_sleep_pattern | 2.01046709 |
| 31 | MP0002735_abnormal_chemical_nociception | 2.00218261 |
| 32 | MP0000778_abnormal_nervous_system | 1.98663976 |
| 33 | MP0001666_abnormal_nutrient_absorption | 1.96214125 |
| 34 | MP0003690_abnormal_glial_cell | 1.95117716 |
| 35 | MP0002736_abnormal_nociception_after | 1.87595217 |
| 36 | MP0003191_abnormal_cellular_cholesterol | 1.86693162 |
| 37 | MP0004885_abnormal_endolymph | 1.85994052 |
| 38 | MP0002067_abnormal_sensory_capabilities | 1.83027688 |
| 39 | MP0001915_intracranial_hemorrhage | 1.80598909 |
| 40 | MP0002733_abnormal_thermal_nociception | 1.79794128 |
| 41 | MP0001958_emphysema | 1.78576599 |
| 42 | MP0001970_abnormal_pain_threshold | 1.74845147 |
| 43 | MP0004924_abnormal_behavior | 1.70723651 |
| 44 | MP0005386_behavior/neurological_phenoty | 1.70723651 |
| 45 | MP0002089_abnormal_postnatal_growth/wei | 1.70363353 |
| 46 | MP0001529_abnormal_vocalization | 1.68526109 |
| 47 | MP0003941_abnormal_skin_development | 1.67496894 |
| 48 | MP0003091_abnormal_cell_migration | 1.64363135 |
| 49 | MP0001905_abnormal_dopamine_level | 1.59228667 |
| 50 | MP0002896_abnormal_bone_mineralization | 1.56991624 |
| 51 | MP0005023_abnormal_wound_healing | 1.55501995 |
| 52 | MP0000566_synostosis | 1.54252330 |
| 53 | * MP0008569_lethality_at_weaning | 1.52895641 |
| 54 | MP0001849_ear_inflammation | 1.52321300 |
| 55 | MP0006276_abnormal_autonomic_nervous | 1.52173703 |
| 56 | MP0002877_abnormal_melanocyte_morpholog | 1.51637615 |
| 57 | MP0002184_abnormal_innervation | 1.50863937 |
| 58 | MP0002557_abnormal_social/conspecific_i | 1.49411309 |
| 59 | MP0010329_abnormal_lipoprotein_level | 1.49249576 |
| 60 | MP0005451_abnormal_body_composition | 1.47187003 |
| 61 | MP0003633_abnormal_nervous_system | 1.46184361 |
| 62 | MP0004142_abnormal_muscle_tone | 1.45832921 |
| 63 | * MP0000955_abnormal_spinal_cord | 1.45186933 |
| 64 | MP0005076_abnormal_cell_differentiation | 1.42890137 |
| 65 | MP0000604_amyloidosis | 1.42757214 |
| 66 | MP0000579_abnormal_nail_morphology | 1.42732241 |
| 67 | MP0004811_abnormal_neuron_physiology | 1.41701321 |
| 68 | MP0004742_abnormal_vestibular_system | 1.41658982 |
| 69 | * MP0002882_abnormal_neuron_morphology | 1.40274822 |
| 70 | * MP0002066_abnormal_motor_capabilities/c | 1.39393044 |
| 71 | MP0010234_abnormal_vibrissa_follicle | 1.36646468 |
| 72 | MP0003631_nervous_system_phenotype | 1.35961132 |
| 73 | MP0005646_abnormal_pituitary_gland | 1.34897996 |
| 74 | MP0003300_gastrointestinal_ulcer | 1.31665491 |
| 75 | MP0003632_abnormal_nervous_system | 1.27485623 |
| 76 | MP0006054_spinal_hemorrhage | 1.27212213 |
| 77 | MP0005551_abnormal_eye_electrophysiolog | 1.25389831 |
| 78 | MP0003279_aneurysm | 1.25303693 |
| 79 | MP0003453_abnormal_keratinocyte_physiol | 1.24929772 |
| 80 | MP0009384_cardiac_valve_regurgitation | 1.24629339 |
| 81 | MP0002060_abnormal_skin_morphology | 1.24511399 |
| 82 | * MP0003634_abnormal_glial_cell | 1.24108202 |
| 83 | MP0004858_abnormal_nervous_system | 1.22487509 |
| 84 | MP0004264_abnormal_extraembryonic_tissu | 1.20959016 |
| 85 | MP0010352_gastrointestinal_tract_polyps | 1.20821386 |
| 86 | * MP0002229_neurodegeneration | 1.18441434 |
| 87 | MP0005171_absent_coat_pigmentation | 1.17595392 |
| 88 | MP0001984_abnormal_olfaction | 1.15698809 |
| 89 | MP0003183_abnormal_peptide_metabolism | 1.11898566 |
| 90 | MP0000767_abnormal_smooth_muscle | 1.11499718 |
| 91 | MP0005645_abnormal_hypothalamus_physiol | 1.10955948 |
| 92 | MP0000762_abnormal_tongue_morphology | 1.09295533 |
| 93 | MP0000534_abnormal_ureter_morphology | 1.09173824 |
| 94 | MP0001177_atelectasis | 1.08270375 |
| 95 | MP0002909_abnormal_adrenal_gland | 1.07751740 |
| 96 | MP0001502_abnormal_circadian_rhythm | 1.06286801 |
| 97 | MP0004233_abnormal_muscle_weight | 1.05731910 |
| 98 | MP0003252_abnormal_bile_duct | 1.04542533 |
| 99 | MP0003879_abnormal_hair_cell | 1.02261740 |
| 100 | * MP0002152_abnormal_brain_morphology | 1.00723051 |
| 101 | MP0008874_decreased_physiological_sensi | 0.99024851 |
| 102 | * MP0005409_darkened_coat_color | 0.97558988 |
| 103 | MP0002139_abnormal_hepatobiliary_system | 0.97354166 |
| 104 | MP0003950_abnormal_plasma_membrane | 0.96763635 |
| 105 | MP0008260_abnormal_autophagy | 0.94247961 |
| 106 | MP0005503_abnormal_tendon_morphology | 0.94050657 |
| 107 | MP0005360_urolithiasis | 0.94027527 |
| 108 | MP0009053_abnormal_anal_canal | 0.93553630 |
| 109 | MP0005535_abnormal_body_temperature | 0.91421950 |
| 110 | MP0000003_abnormal_adipose_tissue | 0.90049975 |
| 111 | MP0001485_abnormal_pinna_reflex | 0.88226776 |
| 112 | MP0002837_dystrophic_cardiac_calcinosis | 0.87903915 |
| 113 | MP0002069_abnormal_eating/drinking_beha | 0.87824593 |
| 114 | MP0000467_abnormal_esophagus_morphology | 0.87684077 |
| 115 | MP0001299_abnormal_eye_distance/ | 0.87362769 |
| 116 | MP0002090_abnormal_vision | 0.86740205 |
| 117 | MP0001963_abnormal_hearing_physiology | 0.86602252 |
| 118 | MP0003115_abnormal_respiratory_system | 0.85654915 |
| 119 | MP0003385_abnormal_body_wall | 0.84817476 |
| 120 | MP0003123_paternal_imprinting | 0.83427760 |
| 121 | MP0001188_hyperpigmentation | 0.82203417 |
| 122 | MP0006138_congestive_heart_failure | 0.79878088 |
| 123 | MP0005085_abnormal_gallbladder_physiolo | 0.79669698 |
| 124 | MP0004145_abnormal_muscle_electrophysio | 0.78976299 |
| 125 | MP0002752_abnormal_somatic_nervous | 0.78774067 |
| 126 | MP0005408_hypopigmentation | 0.77348554 |
| 127 | MP0000537_abnormal_urethra_morphology | 0.77234663 |
| 128 | MP0002876_abnormal_thyroid_physiology | 0.77093359 |
| 129 | MP0000751_myopathy | 0.76926818 |
| 130 | MP0000569_abnormal_digit_pigmentation | 0.76523121 |
| 131 | MP0001661_extended_life_span | 0.75753790 |
| 132 | MP0008872_abnormal_physiological_respon | 0.74552209 |
| 133 | MP0002971_abnormal_brown_adipose | 0.73743130 |
| 134 | MP0004085_abnormal_heartbeat | 0.72772572 |
| 135 | MP0003075_altered_response_to | 0.71785024 |
| 136 | MP0003787_abnormal_imprinting | 0.71500902 |
| 137 | MP0008875_abnormal_xenobiotic_pharmacok | 0.71242033 |
| 138 | MP0005197_abnormal_uvea_morphology | 0.70291345 |
| 139 | MP0000609_abnormal_liver_physiology | 0.70069544 |
| 140 | MP0010386_abnormal_urinary_bladder | 0.69544079 |
| 141 | MP0004019_abnormal_vitamin_homeostasis | 0.69086103 |
| 142 | MP0010630_abnormal_cardiac_muscle | 0.68465302 |
| 143 | MP0005666_abnormal_adipose_tissue | 0.68067392 |
| 144 | MP0005375_adipose_tissue_phenotype | 0.68004860 |
| 145 | MP0005164_abnormal_response_to | 0.67964496 |
| 146 | MP0003942_abnormal_urinary_system | 0.67782898 |
| 147 | MP0002998_abnormal_bone_remodeling | 0.67192561 |
| 148 | MP0001348_abnormal_lacrimal_gland | 0.66688492 |
| 149 | MP0000733_abnormal_muscle_development | 0.66348060 |
| 150 | MP0000013_abnormal_adipose_tissue | 0.65593329 |
| 151 | MP0003195_calcinosis | 0.65485247 |
| 152 | MP0005248_abnormal_Harderian_gland | 0.64348393 |
| 153 | MP0004185_abnormal_adipocyte_glucose | 0.64289743 |
| 154 | MP0005508_abnormal_skeleton_morphology | 0.63526778 |
| 155 | MP0003122_maternal_imprinting | 0.62482221 |
| 156 | MP0000631_abnormal_neuroendocrine_gland | 0.62427803 |
| 157 | MP0002108_abnormal_muscle_morphology | 0.62091371 |
| 158 | MP0005623_abnormal_meninges_morphology | 0.61399161 |
| 159 | MP0001664_abnormal_digestion | 0.60790379 |
| 160 | MP0003137_abnormal_impulse_conducting | 0.59374946 |
| 161 | MP0004043_abnormal_pH_regulation | 0.57468012 |
| 162 | MP0003172_abnormal_lysosome_physiology | 0.57379858 |
| 163 | MP0000462_abnormal_digestive_system | 0.56806708 |
| 164 | MP0003868_abnormal_feces_composition | 0.53762232 |
| 165 | MP0005187_abnormal_penis_morphology | 0.53614061 |
| 166 | MP0001943_abnormal_respiration | 0.52950091 |
| 167 | MP0000747_muscle_weakness | 0.51928936 |
| 168 | MP0004130_abnormal_muscle_cell | 0.51642788 |
| 169 | MP0002295_abnormal_pulmonary_circulatio | 0.51213095 |
| 170 | MP0002118_abnormal_lipid_homeostasis | 0.51027020 |
| 171 | MP0005195_abnormal_posterior_eye | 0.50246129 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 6.32874455 |
| 2 | Myokymia (HP:0002411) | 5.80661034 |
| 3 | Focal seizures (HP:0007359) | 4.87016740 |
| 4 | Neurofibrillary tangles (HP:0002185) | 4.55596120 |
| 5 | Protrusio acetabuli (HP:0003179) | 4.39479168 |
| 6 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 4.21889780 |
| 7 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 4.21889780 |
| 8 | Abnormality of the corticospinal tract (HP:0002492) | 4.18616263 |
| 9 | Cerebral inclusion bodies (HP:0100314) | 4.15020595 |
| 10 | Atonic seizures (HP:0010819) | 4.02252178 |
| 11 | Complement deficiency (HP:0004431) | 3.99812984 |
| 12 | Action tremor (HP:0002345) | 3.93021839 |
| 13 | Supranuclear gaze palsy (HP:0000605) | 3.88449327 |
| 14 | Visual hallucinations (HP:0002367) | 3.82551830 |
| 15 | Epileptic encephalopathy (HP:0200134) | 3.77664947 |
| 16 | Insidious onset (HP:0003587) | 3.73361666 |
| 17 | Termporal pattern (HP:0011008) | 3.73361666 |
| 18 | Progressive cerebellar ataxia (HP:0002073) | 3.73069474 |
| 19 | Premature rupture of membranes (HP:0001788) | 3.72728863 |
| 20 | Dysmetria (HP:0001310) | 3.53382878 |
| 21 | Hyperventilation (HP:0002883) | 3.50575510 |
| 22 | Absence seizures (HP:0002121) | 3.48520503 |
| 23 | Spastic gait (HP:0002064) | 3.46849395 |
| 24 | Scanning speech (HP:0002168) | 3.45433848 |
| 25 | Abnormality of complement system (HP:0005339) | 3.35459607 |
| 26 | Arterial tortuosity (HP:0005116) | 3.31698785 |
| 27 | Generalized tonic-clonic seizures (HP:0002069) | 3.28677514 |
| 28 | Febrile seizures (HP:0002373) | 3.26752663 |
| 29 | Broad-based gait (HP:0002136) | 3.26380585 |
| 30 | Impaired vibration sensation in the lower limbs (HP:0002166) | 3.25165462 |
| 31 | Dialeptic seizures (HP:0011146) | 3.24795205 |
| 32 | Intention tremor (HP:0002080) | 3.22448998 |
| 33 | Atrophic scars (HP:0001075) | 3.21648091 |
| 34 | Vascular tortuosity (HP:0004948) | 3.18812084 |
| 35 | Urinary bladder sphincter dysfunction (HP:0002839) | 3.13640984 |
| 36 | Ankle clonus (HP:0011448) | 3.08187924 |
| 37 | Dysdiadochokinesis (HP:0002075) | 3.07016105 |
| 38 | Prolonged partial thromboplastin time (HP:0003645) | 3.05449514 |
| 39 | Abnormality of the common coagulation pathway (HP:0010990) | 3.04199221 |
| 40 | Glomerulonephritis (HP:0000099) | 2.95741006 |
| 41 | Mitral stenosis (HP:0001718) | 2.90728118 |
| 42 | Gaze-evoked nystagmus (HP:0000640) | 2.87664664 |
| 43 | Poor eye contact (HP:0000817) | 2.85055391 |
| 44 | Systemic lupus erythematosus (HP:0002725) | 2.84977049 |
| 45 | Cerebral aneurysm (HP:0004944) | 2.81832543 |
| 46 | Truncal ataxia (HP:0002078) | 2.79658667 |
| 47 | Urinary urgency (HP:0000012) | 2.77464253 |
| 48 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.77357006 |
| 49 | Flat acetabular roof (HP:0003180) | 2.76296411 |
| 50 | Joint hemorrhage (HP:0005261) | 2.70290529 |
| 51 | Abnormal eating behavior (HP:0100738) | 2.70220900 |
| 52 | Drooling (HP:0002307) | 2.69046747 |
| 53 | Excessive salivation (HP:0003781) | 2.69046747 |
| 54 | Anxiety (HP:0000739) | 2.68784617 |
| 55 | Abnormal social behavior (HP:0012433) | 2.67733736 |
| 56 | Impaired social interactions (HP:0000735) | 2.67733736 |
| 57 | Lower limb muscle weakness (HP:0007340) | 2.64989592 |
| 58 | Hypobetalipoproteinemia (HP:0003563) | 2.61884260 |
| 59 | Blue irides (HP:0000635) | 2.61303729 |
| 60 | Aortic dissection (HP:0002647) | 2.57783627 |
| 61 | Postural instability (HP:0002172) | 2.55860712 |
| 62 | Vertebral compression fractures (HP:0002953) | 2.51994184 |
| 63 | Abnormality of carpal bone ossification (HP:0006257) | 2.49001239 |
| 64 | Neonatal short-limb short stature (HP:0008921) | 2.47882379 |
| 65 | Torticollis (HP:0000473) | 2.47523521 |
| 66 | Sensory axonal neuropathy (HP:0003390) | 2.45846881 |
| 67 | Depression (HP:0000716) | 2.42492468 |
| 68 | Xanthomatosis (HP:0000991) | 2.41406594 |
| 69 | Mutism (HP:0002300) | 2.40033405 |
| 70 | Hypercholesterolemia (HP:0003124) | 2.35208598 |
| 71 | Pheochromocytoma (HP:0002666) | 2.35153857 |
| 72 | Epileptiform EEG discharges (HP:0011182) | 2.34631499 |
| 73 | Wormian bones (HP:0002645) | 2.29631763 |
| 74 | Akinesia (HP:0002304) | 2.29287240 |
| 75 | Generalized myoclonic seizures (HP:0002123) | 2.27765897 |
| 76 | Impaired vibratory sensation (HP:0002495) | 2.27694240 |
| 77 | Onion bulb formation (HP:0003383) | 2.26656778 |
| 78 | EEG with generalized epileptiform discharges (HP:0011198) | 2.26387952 |
| 79 | Cardiovascular calcification (HP:0011915) | 2.25368092 |
| 80 | Hemorrhage of the eye (HP:0011885) | 2.22300564 |
| 81 | Shallow orbits (HP:0000586) | 2.22006433 |
| 82 | Focal dystonia (HP:0004373) | 2.19246427 |
| 83 | Polyphagia (HP:0002591) | 2.19099661 |
| 84 | Abnormal ossification of hand bones (HP:0005921) | 2.18099809 |
| 85 | Papilledema (HP:0001085) | 2.17919908 |
| 86 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.17343453 |
| 87 | Mucopolysacchariduria (HP:0008155) | 2.17343453 |
| 88 | Hypsarrhythmia (HP:0002521) | 2.16618999 |
| 89 | Genetic anticipation (HP:0003743) | 2.16064166 |
| 90 | Amblyopia (HP:0000646) | 2.15850626 |
| 91 | Cervical subluxation (HP:0003308) | 2.15618961 |
| 92 | Fragile skin (HP:0001030) | 2.15576032 |
| 93 | Asymmetry of the thorax (HP:0001555) | 2.15036991 |
| 94 | Neuronal loss in central nervous system (HP:0002529) | 2.14613067 |
| 95 | Hemiparesis (HP:0001269) | 2.13543189 |
| 96 | Absent speech (HP:0001344) | 2.12169854 |
| 97 | Megalencephaly (HP:0001355) | 2.11312980 |
| 98 | Peripheral hypomyelination (HP:0007182) | 2.10982327 |
| 99 | Vascular calcification (HP:0004934) | 2.10976806 |
| 100 | Progressive inability to walk (HP:0002505) | 2.09416727 |
| 101 | Diplopia (HP:0000651) | 2.08380546 |
| 102 | Abnormality of binocular vision (HP:0011514) | 2.08380546 |
| 103 | Limb dystonia (HP:0002451) | 2.06152935 |
| 104 | Bladder diverticulum (HP:0000015) | 2.05706411 |
| 105 | Abnormality of the Achilles tendon (HP:0005109) | 2.05371826 |
| 106 | Skin nodule (HP:0200036) | 2.04661570 |
| 107 | Mitral valve prolapse (HP:0001634) | 2.04325230 |
| 108 | Craniofacial dystonia (HP:0012179) | 2.04189930 |
| 109 | Abnormality of the acetabulum (HP:0003170) | 2.03703820 |
| 110 | Morphological abnormality of the pyramidal tract (HP:0002062) | 2.01191790 |
| 111 | Aplasia involving bones of the upper limbs (HP:0009823) | 2.00758296 |
| 112 | Aplasia of the phalanges of the hand (HP:0009802) | 2.00758296 |
| 113 | Aplasia involving bones of the extremities (HP:0009825) | 2.00758296 |
| 114 | Peritonitis (HP:0002586) | 2.00667029 |
| 115 | Ulnar bowing (HP:0003031) | 1.99690835 |
| 116 | Clonus (HP:0002169) | 1.99400967 |
| 117 | Dysostosis multiplex (HP:0000943) | 1.99031880 |
| 118 | Aneurysm (HP:0002617) | 1.98921226 |
| 119 | Conjugated hyperbilirubinemia (HP:0002908) | 1.98638786 |
| 120 | Back pain (HP:0003418) | 1.97003492 |
| 121 | Menorrhagia (HP:0000132) | 1.96474519 |
| 122 | Abnormality of polysaccharide metabolism (HP:0011012) | 1.95370126 |
| 123 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 1.95370126 |
| 124 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 1.95370126 |
| 125 | Nephritis (HP:0000123) | 1.95163145 |
| 126 | Aortic aneurysm (HP:0004942) | 1.94126971 |
| 127 | Fetal akinesia sequence (HP:0001989) | 1.92535903 |
| 128 | Hemiplegia (HP:0002301) | 1.91256024 |
| 129 | Abnormality of salivation (HP:0100755) | 1.89686945 |
| 130 | Blue sclerae (HP:0000592) | 1.89321215 |
| 131 | Status epilepticus (HP:0002133) | 1.89252757 |
| 132 | Hypolipoproteinemia (HP:0010981) | 1.86354374 |
| 133 | Increased circulating renin level (HP:0000848) | 1.86302094 |
| 134 | Clumsiness (HP:0002312) | 1.86177197 |
| 135 | Neuroendocrine neoplasm (HP:0100634) | 1.85872157 |
| 136 | Stereotypic behavior (HP:0000733) | 1.85674697 |
| 137 | Thin bony cortex (HP:0002753) | 1.85451875 |
| 138 | Cupped ribs (HP:0000887) | 1.85377002 |
| 139 | Abnormal hand bone ossification (HP:0010660) | 1.85076449 |
| 140 | Bradykinesia (HP:0002067) | 1.84867366 |
| 141 | Hammertoe (HP:0001765) | 1.84860346 |
| 142 | Vertebral arch anomaly (HP:0008438) | 1.84852269 |
| 143 | Hyperextensible skin (HP:0000974) | 1.84510554 |
| 144 | Psychosis (HP:0000709) | 1.83424952 |
| 145 | Cerebral hemorrhage (HP:0001342) | 1.83106937 |
| 146 | Abnormality of dentin (HP:0010299) | 1.82192060 |
| 147 | Impaired smooth pursuit (HP:0007772) | 1.80577160 |
| 148 | Hyperacusis (HP:0010780) | 1.80397443 |
| 149 | Advanced eruption of teeth (HP:0006288) | 1.80395839 |
| 150 | Retinal dysplasia (HP:0007973) | 1.79369195 |
| 151 | Abnormal delivery (HP:0001787) | 1.79069676 |
| 152 | Thickened helices (HP:0000391) | 1.78931579 |
| 153 | Abnormality of saccadic eye movements (HP:0000570) | 1.76687439 |
| 154 | Widely spaced teeth (HP:0000687) | 1.76432323 |
| 155 | Neonatal death (HP:0003811) | 1.76046052 |
| 156 | Right ventricular cardiomyopathy (HP:0011663) | 1.75213958 |
| 157 | Deep venous thrombosis (HP:0002625) | 1.75082990 |
| 158 | Amyloidosis (HP:0011034) | 1.74754088 |
| 159 | Coxa vara (HP:0002812) | 1.74686812 |
| 160 | Mitral regurgitation (HP:0001653) | 1.74025358 |
| 161 | Bronchomalacia (HP:0002780) | 1.73515649 |
| 162 | Achilles tendon contracture (HP:0001771) | 1.72978328 |
| 163 | Gait ataxia (HP:0002066) | 1.72685086 |
| 164 | Postural tremor (HP:0002174) | 1.72055098 |
| 165 | Abnormality of the intrinsic pathway (HP:0010989) | 1.71299995 |
| 166 | Bowel incontinence (HP:0002607) | 1.70423622 |
| 167 | Soft skin (HP:0000977) | 1.70279063 |
| 168 | Fair hair (HP:0002286) | 1.70063123 |
| 169 | Slow saccadic eye movements (HP:0000514) | 1.69896986 |
| 170 | Spinal rigidity (HP:0003306) | 1.69734477 |
| 171 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 1.69706496 |
| 172 | Biconcave vertebral bodies (HP:0004586) | 1.68986989 |
| 173 | Spastic tetraparesis (HP:0001285) | 1.68816421 |
| 174 | Hypoplastic nipples (HP:0002557) | 1.68231831 |
| 175 | Ankle contracture (HP:0006466) | 1.66977200 |
| 176 | Myocardial infarction (HP:0001658) | 1.66037638 |
| 177 | Abnormality of the lumbar spine (HP:0100712) | 1.65618361 |
| 178 | Upper limb amyotrophy (HP:0009129) | 1.65595241 |
| 179 | Distal upper limb amyotrophy (HP:0007149) | 1.65595241 |
| 180 | Osteoarthritis (HP:0002758) | 1.64253322 |
| 181 | Short nail (HP:0001799) | 1.64107472 |
| 182 | Ankyloglossia (HP:0010296) | 1.62967956 |
| 183 | Broad metatarsal (HP:0001783) | 1.61077011 |
| 184 | Wide anterior fontanel (HP:0000260) | 1.60712398 |
| 185 | Intrahepatic cholestasis (HP:0001406) | 1.60573895 |
| 186 | Dilatation of the ascending aorta (HP:0005111) | 1.60415345 |
| 187 | Turricephaly (HP:0000262) | 1.59398439 |
| 188 | Broad face (HP:0000283) | 1.58388956 |
| 189 | Flared iliac wings (HP:0002869) | 1.58128391 |
| 190 | Abnormal tarsal ossification (HP:0008369) | 1.58100778 |
| 191 | Ovoid vertebral bodies (HP:0003300) | 1.56961299 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EPHA4 | 4.36926819 |
| 2 | RIPK1 | 3.77981200 |
| 3 | NTRK3 | 3.60465952 |
| 4 | PDGFRA | 3.27026160 |
| 5 | TRIB3 | 3.11331123 |
| 6 | FGFR4 | 2.96739907 |
| 7 | MARK1 | 2.86284155 |
| 8 | MAP3K9 | 2.84989472 |
| 9 | CDK12 | 2.71473792 |
| 10 | MAP3K4 | 2.51412818 |
| 11 | STK39 | 2.28065275 |
| 12 | MINK1 | 2.17578514 |
| 13 | ERN1 | 2.17241903 |
| 14 | TNIK | 2.16233147 |
| 15 | NTRK1 | 2.08940431 |
| 16 | OXSR1 | 2.08428270 |
| 17 | PAK6 | 2.06795695 |
| 18 | CASK | 2.05748828 |
| 19 | DDR2 | 2.01230786 |
| 20 | DAPK2 | 1.98559292 |
| 21 | EEF2K | 1.89935506 |
| 22 | MAP2K7 | 1.89538543 |
| 23 | RIPK4 | 1.88683509 |
| 24 | FGFR3 | 1.79770995 |
| 25 | SIK1 | 1.76445654 |
| 26 | NTRK2 | 1.68747341 |
| 27 | PNCK | 1.68728494 |
| 28 | MAP2K4 | 1.67925452 |
| 29 | LATS1 | 1.64986298 |
| 30 | KSR2 | 1.63035488 |
| 31 | PTK2 | 1.58839024 |
| 32 | TTN | 1.48299289 |
| 33 | CDK5 | 1.45314066 |
| 34 | PLK2 | 1.44678730 |
| 35 | TGFBR2 | 1.39537683 |
| 36 | MST1R | 1.36262056 |
| 37 | PRKD3 | 1.36006173 |
| 38 | PKN2 | 1.34858392 |
| 39 | PRPF4B | 1.34115902 |
| 40 | FGFR2 | 1.32744590 |
| 41 | EPHB2 | 1.28866737 |
| 42 | EPHA2 | 1.24284208 |
| 43 | FES | 1.22387858 |
| 44 | GRK5 | 1.22134005 |
| 45 | KSR1 | 1.21497654 |
| 46 | TYRO3 | 1.19799089 |
| 47 | CAMK2B | 1.19528622 |
| 48 | CAMK1G | 1.18902808 |
| 49 | IRAK3 | 1.18635307 |
| 50 | CAMKK1 | 1.18148049 |
| 51 | CAMK2A | 1.17377000 |
| 52 | MAPK13 | 1.17101092 |
| 53 | SGK223 | 1.16521148 |
| 54 | SGK494 | 1.16521148 |
| 55 | PDGFRB | 1.16066508 |
| 56 | UHMK1 | 1.16058016 |
| 57 | CDK19 | 1.15737405 |
| 58 | AKT3 | 1.14557476 |
| 59 | PAK3 | 1.12791280 |
| 60 | PKN1 | 1.11471672 |
| 61 | BCR | 1.10570746 |
| 62 | SCYL2 | 1.08935967 |
| 63 | WNK1 | 1.07344979 |
| 64 | MAP3K2 | 1.06370532 |
| 65 | CSNK1G2 | 1.06197974 |
| 66 | MTOR | 1.05812421 |
| 67 | NEK9 | 1.05542429 |
| 68 | MAP3K12 | 1.03909973 |
| 69 | PHKG2 | 1.00962669 |
| 70 | PHKG1 | 1.00962669 |
| 71 | PTK2B | 0.98747150 |
| 72 | FGR | 0.96265049 |
| 73 | MAP3K13 | 0.96019819 |
| 74 | CDC42BPA | 0.95380144 |
| 75 | ARAF | 0.94426164 |
| 76 | PRKCG | 0.94114816 |
| 77 | PRKCH | 0.93991910 |
| 78 | EPHB1 | 0.93861103 |
| 79 | SMG1 | 0.93169322 |
| 80 | PAK2 | 0.91962318 |
| 81 | TESK1 | 0.88774154 |
| 82 | STK11 | 0.87721318 |
| 83 | NEK6 | 0.85154530 |
| 84 | CAMK2D | 0.84667535 |
| 85 | WNK4 | 0.84386725 |
| 86 | STK38 | 0.82978372 |
| 87 | MOS | 0.82174408 |
| 88 | RET | 0.81526139 |
| 89 | ROCK2 | 0.78627776 |
| 90 | CAMK2G | 0.78257545 |
| 91 | RPS6KA2 | 0.77350742 |
| 92 | BMPR2 | 0.77194661 |
| 93 | MARK2 | 0.76830262 |
| 94 | PAK4 | 0.76090070 |
| 95 | CDK14 | 0.75869261 |
| 96 | CDK15 | 0.75341708 |
| 97 | CSNK1A1L | 0.74924311 |
| 98 | CDK18 | 0.74508530 |
| 99 | SIK2 | 0.74271178 |
| 100 | PDPK1 | 0.73668009 |
| 101 | EPHA3 | 0.72317013 |
| 102 | CSNK1G3 | 0.71921962 |
| 103 | SGK1 | 0.71846472 |
| 104 | PRKCE | 0.71154579 |
| 105 | ICK | 0.71039606 |
| 106 | MAPKAPK5 | 0.70260549 |
| 107 | DAPK1 | 0.69702860 |
| 108 | FGFR1 | 0.67716191 |
| 109 | FYN | 0.66571943 |
| 110 | MAP3K1 | 0.64420628 |
| 111 | CAMK1 | 0.62814959 |
| 112 | CAMKK2 | 0.61933378 |
| 113 | CDK11A | 0.61548348 |
| 114 | INSRR | 0.61277897 |
| 115 | DYRK1A | 0.60967980 |
| 116 | PTK6 | 0.59184109 |
| 117 | SGK2 | 0.58336110 |
| 118 | PRKCQ | 0.57767796 |
| 119 | CDK6 | 0.57551943 |
| 120 | PDK1 | 0.57131324 |
| 121 | BRD4 | 0.56402594 |
| 122 | ERBB2 | 0.56052784 |
| 123 | MAP3K6 | 0.55790992 |
| 124 | MAP3K3 | 0.55500275 |
| 125 | PRKCZ | 0.55372753 |
| 126 | RAF1 | 0.54876024 |
| 127 | JAK1 | 0.54812903 |
| 128 | LMTK2 | 0.53267676 |
| 129 | CSNK1G1 | 0.53148734 |
| 130 | SGK3 | 0.51030934 |
| 131 | FER | 0.50497527 |
| 132 | MAPK11 | 0.50318974 |
| 133 | PIK3CA | 0.50034059 |
| 134 | ERBB4 | 0.48273451 |
| 135 | LATS2 | 0.47381785 |
| 136 | PRKAA2 | 0.47183002 |
| 137 | RPS6KA3 | 0.47096450 |
| 138 | DMPK | 0.44881145 |
| 139 | LIMK1 | 0.44668369 |
| 140 | CAMK1D | 0.43465283 |
| 141 | BMX | 0.43448931 |
| 142 | PRKG1 | 0.43442954 |
| 143 | RPS6KB1 | 0.43442740 |
| 144 | SRC | 0.42835527 |
| 145 | MAP3K7 | 0.42567457 |
| 146 | PRKD2 | 0.41045282 |
| 147 | PINK1 | 0.40681467 |
| 148 | MET | 0.38266598 |
| 149 | MAPK10 | 0.38203377 |
| 150 | PIM2 | 0.37783209 |
| 151 | TRPM7 | 0.36818774 |
| 152 | PRKG2 | 0.35012566 |
| 153 | MAPKAPK3 | 0.34441108 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Nicotine addiction_Homo sapiens_hsa05033 | 3.09528171 |
| 2 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.39251007 |
| 3 | GABAergic synapse_Homo sapiens_hsa04727 | 2.39065748 |
| 4 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.35934763 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.30092378 |
| 6 | Nitrogen metabolism_Homo sapiens_hsa00910 | 2.26726598 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.23919842 |
| 8 | Morphine addiction_Homo sapiens_hsa05032 | 2.17629836 |
| 9 | Long-term potentiation_Homo sapiens_hsa04720 | 2.12302180 |
| 10 | Olfactory transduction_Homo sapiens_hsa04740 | 1.94265128 |
| 11 | Salivary secretion_Homo sapiens_hsa04970 | 1.93363085 |
| 12 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.92841691 |
| 13 | Other glycan degradation_Homo sapiens_hsa00511 | 1.92033249 |
| 14 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.84337458 |
| 15 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.78860699 |
| 16 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.69336640 |
| 17 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.65069071 |
| 18 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.63347586 |
| 19 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.62766972 |
| 20 | Long-term depression_Homo sapiens_hsa04730 | 1.60275414 |
| 21 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.59725790 |
| 22 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.58290849 |
| 23 | Renin secretion_Homo sapiens_hsa04924 | 1.53226195 |
| 24 | Insulin secretion_Homo sapiens_hsa04911 | 1.51261040 |
| 25 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.50426401 |
| 26 | Cocaine addiction_Homo sapiens_hsa05030 | 1.49639457 |
| 27 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.46028569 |
| 28 | Axon guidance_Homo sapiens_hsa04360 | 1.42961283 |
| 29 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.41362214 |
| 30 | Taste transduction_Homo sapiens_hsa04742 | 1.41206942 |
| 31 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.33892440 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.32302941 |
| 33 | Focal adhesion_Homo sapiens_hsa04510 | 1.31055617 |
| 34 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.31039471 |
| 35 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.26377040 |
| 36 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.25805172 |
| 37 | Amoebiasis_Homo sapiens_hsa05146 | 1.25242489 |
| 38 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.22819036 |
| 39 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.20639106 |
| 40 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.17920491 |
| 41 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 1.17475956 |
| 42 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.14455348 |
| 43 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.13589483 |
| 44 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.13454678 |
| 45 | Adherens junction_Homo sapiens_hsa04520 | 1.13016534 |
| 46 | Gap junction_Homo sapiens_hsa04540 | 1.12316961 |
| 47 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.12088700 |
| 48 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.09623277 |
| 49 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.08522219 |
| 50 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.07264481 |
| 51 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.06910031 |
| 52 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.06701302 |
| 53 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 1.06610248 |
| 54 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.06568602 |
| 55 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.04928602 |
| 56 | Phototransduction_Homo sapiens_hsa04744 | 1.01962249 |
| 57 | Bile secretion_Homo sapiens_hsa04976 | 1.00865793 |
| 58 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.99124550 |
| 59 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.98822885 |
| 60 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.97735843 |
| 61 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.96573823 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96290496 |
| 63 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.96052742 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.95604215 |
| 65 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.93848286 |
| 66 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.93728640 |
| 67 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.92939329 |
| 68 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.91804529 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.91099457 |
| 70 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.90945432 |
| 71 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.90588089 |
| 72 | Lysosome_Homo sapiens_hsa04142 | 0.89483477 |
| 73 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.88059494 |
| 74 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.87448938 |
| 75 | Retinol metabolism_Homo sapiens_hsa00830 | 0.85584879 |
| 76 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.85228762 |
| 77 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.84070080 |
| 78 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.84064356 |
| 79 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.83966879 |
| 80 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.83828379 |
| 81 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83732164 |
| 82 | Melanogenesis_Homo sapiens_hsa04916 | 0.82834730 |
| 83 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.82616504 |
| 84 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.82203519 |
| 85 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.82174475 |
| 86 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81891071 |
| 87 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.81004182 |
| 88 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.80777142 |
| 89 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.80658269 |
| 90 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.80137452 |
| 91 | Endometrial cancer_Homo sapiens_hsa05213 | 0.80084747 |
| 92 | Galactose metabolism_Homo sapiens_hsa00052 | 0.79692890 |
| 93 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.78790858 |
| 94 | Glioma_Homo sapiens_hsa05214 | 0.78537858 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.77508253 |
| 96 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.77473993 |
| 97 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.74825897 |
| 98 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.74462828 |
| 99 | Bladder cancer_Homo sapiens_hsa05219 | 0.73957602 |
| 100 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.72388926 |
| 101 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.71793874 |
| 102 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.71462120 |
| 103 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.71291651 |
| 104 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.69802675 |
| 105 | Insulin resistance_Homo sapiens_hsa04931 | 0.69338146 |
| 106 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.68950955 |
| 107 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.68341889 |
| 108 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.67979637 |
| 109 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.66543806 |
| 110 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.66474426 |
| 111 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.65985347 |
| 112 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.65750097 |
| 113 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.65182304 |
| 114 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.65162745 |
| 115 | Thyroid cancer_Homo sapiens_hsa05216 | 0.64401972 |
| 116 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.64329428 |
| 117 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.64212525 |
| 118 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.63773468 |
| 119 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.63030200 |
| 120 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.62092627 |
| 121 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.61756183 |
| 122 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.61698914 |
| 123 | Pertussis_Homo sapiens_hsa05133 | 0.60923936 |
| 124 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.60748260 |
| 125 | Lysine degradation_Homo sapiens_hsa00310 | 0.59111620 |
| 126 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.58308131 |
| 127 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.57875055 |
| 128 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.57873867 |
| 129 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.56885631 |
| 130 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.56418789 |
| 131 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.56177067 |
| 132 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.52544635 |
| 133 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.52257444 |
| 134 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.51437809 |
| 135 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.50919574 |
| 136 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.49900754 |
| 137 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.48923978 |
| 138 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.48614724 |
| 139 | Alzheimers disease_Homo sapiens_hsa05010 | 0.47645394 |
| 140 | Prion diseases_Homo sapiens_hsa05020 | 0.47268034 |
| 141 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.47202848 |
| 142 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.46365299 |
| 143 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.44480836 |
| 144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.43588212 |
| 145 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.42522732 |
| 146 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.40987669 |
| 147 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39000701 |
| 148 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.38765941 |
| 149 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.37962321 |
| 150 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.35763449 |
| 151 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.34602683 |
| 152 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.34574754 |
| 153 | Endocytosis_Homo sapiens_hsa04144 | 0.33787257 |
| 154 | Histidine metabolism_Homo sapiens_hsa00340 | 0.33390148 |
| 155 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.32698410 |
| 156 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.30483230 |
| 157 | ABC transporters_Homo sapiens_hsa02010 | 0.29770111 |
| 158 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.29653606 |
| 159 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.27948571 |
| 160 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.24996539 |
| 161 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.24032866 |

